Adjuvant atezolizumab-bevacizumab after curative therapy for hepatocellular carcinoma.

ABSTRACT:

SUBMITTER: Kudo M 

PROVIDER: S-EPMC10282679 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature